Athanasios A. Papageorgiou

Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

Vasilios G. Athyros, Athanasios A. Papageorgiou, Bodosakis R. Mercouris et al. · Current Medical Research and Opinion · 2002 · 531 citations

Medicine, Cardiology, Pharmacotherapy +15

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study

Vasilios G. Athyros, D. P. Mikhailidis, Athanasios A. Papageorgiou et al. · Journal of Clinical Pathology · 2004 · 355 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Atorvastatin and Micronized Fenofibrate Alone and in Combination in Type 2 Diabetes With Combined Hyperlipidemia

Vasilios G. Athyros, Athanasios A. Papageorgiou, Valasia V. Athyrou et al. · Diabetes Care · 2002 · 260 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study

Vasilios G. Athyros, Moses Elisaf, Athanasios A. Papageorgiou et al. · American Journal of Kidney Diseases · 2004 · 208 citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +10

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study

Vasilios G. Athyros, D. P. Mikhailidis, Evangelos Liberopoulos et al. · Nephrology Dialysis Transplantation · 2006 · 184 citations

Medicine, Cardiology, Nephrology +13